Hepatitis B Diagnostic Tests Market is projected to register a CAGR of 6.4% between 2022 and 2028

In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country.

As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3% – 4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1332

Global Hepatitis B Diagnostic Tests Market: Segmentation And Forecast

The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.

• On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Mn in the year 2017 and is likely to reach a valuation of nearly US$ 1,100 Mn in 2027, accounting for a CAGR of 6.2% during the assessment period 2017-2027.
• On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Mn in 2017 and is estimated to reach a valuation of nearly US$ 460 Mn in 2027, registering a CAGR of 6.1% during the period of assessment.
• On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Mn in 2017 and is likely to reach a valuation of nearly US$ 380 Mn in 2027, accounting for a CAGR of 7.2% during the period of forecast.

Global Hepatitis B Diagnostic Tests Market: Competitive Landscape

This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.

Hepatitis B Diagnostic Tests Market By CategoryProduct Type:

• Enzyme Immunoassay Kits
  • Hepatitis B Surface Antigen Test
  • Anti-Hepatitis B Surface Antibody Test
  • Anti-Hepatitis B Core Antibody Test
• Point-of-Care Testing Kits
  • Strips
  • Cassettes/Cards

 End User:

• Hospitals
• Clinics
• Diagnostic Centres
• Home Care

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1332

Region:

• North America
• Western Europe
• Eastern Europe
• Latin America
• Asia-Pacific excluding Japan
• Japan
• Middle East and Africa